Divisão de Ensaios Clínicos e Farmacovigilância
Ramal
2627-2126
Center
Ensaios Clínicos
Contact
vera.gattas@butantan.gov.br
Director
Vera Lucia Gattas
Observação - interna
Alterado em 22/08 por Marcelo Eiji Koike para Divisão de ensaios Clínicos e Farmacovigilância. Alterar registros antigos (nome anterior: apenas Ensaios Clínicos. Alterado por solicitação de Vera Gattas). Alterado na portaria de 2019 para: Centro de Ensaios Clínicos e Farmacovigilância
Laboratory Name
Divisão de Ensaios Clínicos e Farmacovigilância
Research Outputs
(All)
Subject
Results 1-20 of 21 (Search time: 0.005 seconds).
After the pandemic [2020]
Palacios, Ricardo

Braz. J. Infect. Dis. v. 24, n. 3, p. 189-190, mai/jun. 2020
Bystander risk, social value, and ethics of human research [2018]
Shah, S.K.; Kimmelman, J.; Lyerly, A.D.; Lynch, H.F.; Miller, F.G.; Palacios, Ricardo
Science v. 360, n. 6385, p. 158-159, abr. 2018
Custo-efetividade da prótese implanto-suportada comparada à prótese total convencional [2019]
Probst, Livia Fernandes; Vanni, Tazio
Rev saude publica v. 53, n. 69, ago. 2019
Dengue illness index [2018]
Thomas, Stephen J.; Agulto, Liane; Hendrickx, Kim; Erpicum, Martin; Tomashek, Kay Marie; Cassetti, Maria Cristina; Laughlin, Catherine A.; Precioso, Alexander Roberto
PLoS Negl. Trop. Dis. v. 12, n. 10, e0006593, 2018
Development of standard clinical endpoints for use in dengue interventional trials [2018]
Tomashek, Kay Marie; Wills, Bridget A.; See Lum, Lucy Chai; Thomas, Laurent; Durbin, Anna P.; Leo, Yee Sin; De Bosch, Norma Blumenfeld; Rojas, Elsa; Hendrickx, Kim; Erpicum, Martin; Agulto, Liane; Jäenisch, Thomas; Tissera, Hasitha Aravinda; Suntarattiwong, Piyarat; Collers, Beth Ann; Wallace, Derek; Schmidt, Alexander C.; Precioso, Alexander Roberto
Plos Neglect. Trop. Dis. v. 12, n. 10, e0006497, 2018
Development of vaccines against Zika virus [2018]
Poland, Gregory A.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Palacios, Ricardo

Lancet Infect. Dis. v. 18, n. 7, p. e211-e219, jul. 2018
Double-Blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (Inactivated) vaccine manufactured by Sinovac – PROFISCOV [2020]
Palácios, Ricardo




Trials v. 21, 853, out. 2020
Epidemiologia dos acidentes por animais peçonhentos e a distribuição de soros [2018]
Salomão, Maria da Graça
Rev Salud Publica (Bogota) v. 20, n. 4, p. 523-529, jul./ago. 2018
Forgotten, but not forgiven [2018]
Palacios, Ricardo
Colomb. Med. v. 49, n. 3, p. 189-192, jul./set. 2018
La ética de los diseños y métodos alternativos de ensayos clínicos [2018]
Saenz, Carla; Luna, Florencia; Salas, Sofía P.; Canario, Julio Arturo; Chamorro, Jackeline Bravo; Palacios, Ricardo
Rev Panam Salud Publica v. 42, e38, jan. 2018
Landscape analysis of pharmacovigilance and related practices among 34 vaccine manufacturers’ from emerging countries [2020]
Hartmann, Katharina; Pagliusi, Sonia; Precioso, Alexander Roberto
Vaccine v. 38, n. 34, p. 5490-5497, jul. 2020
Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic [2020]
Palacios, Ricardo
Colomb Med. v. 51, n. 2, e-4276, maio. 2020
Vacinas contra DifteriaTétano e Coqueluche AcelularEfeitos Colaterais e Reações Adversas Relacionados a MedicamentosSegurançaVigilância
Ocorrência de eventos adversos após o uso da vacina adsorvida difteria, tétano e pertussis (acelular) – dTpa –, São Paulo, SP, 2015-2016 [2020]
Gattás, Vera Lúcia
Epidemiol. Serv. Saude v. 29, n. 2, e2019280, maio. 2020
Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis [2018]
Sampaio-Barros, Percival D.; Andrade, Danieli C. O.; Seguro, Luciana C. P.; Pasoto, Sandra G.; Viana, Vilma S. T.; Ribeiro, Ana C. M.; Aikawa, Nadia E.; Timenetsky, Maria do Carmo S.; Precioso, Alexander Roberto
Rheumatology v. 57, n. 10, p. 1721–1725, out. 2018
Pharmacovigilance capacity strengthening for WHO prequalification [2019]
Koike, Marcelo Eiji






Vaccine v. 37, n. 52, p. 7560-7565, dez. 2019
Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan [2018]
Mondini, Gabriela


Rev Inst Med Trop Sao Paulo v. 60, e37, jul. 2018
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil [2020]
Kallas, Esper Georges; Precioso, Alexander Roberto











Lancet Infect. Dis. v. 20, n. 7, p. 839-850, mar. 2020
Influenza vaccineAdverse events following immunization (AEFI)Safety vaccinesSurveillanceInstituto Butantan
Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017 [2019]
Gattás, Vera Lúcia







Rev. Inst. Med. trop. S. Paulo v. 61, e4, jan. 2019
When could human challenge trials be deployed to combat emerging infectious diseases? Lessons from the case of a Zika virus human challenge trial [2019]
Palacios, Ricardo
Trials v. 20, suppl. 2, 702, dez. 2019